PARKINSON'S DISEASE NEWS

5th March 2011 - New research

USE OF IBUPROFEN AND THE RISK OF PARKINSON'S DISEASE

Neurology [2011] Mar 2 [Epub ahead of print] (Gao X, Chen H, Schwarzschild MA, Ascherio A.) Complete abstract

Use of non-steroidal anti-inflammatory drugs (NSAID) in general, and possibly Ibuprofen in particular, has been claimed to be related to a lower risk of Parkinson's Disease. It has consequently been claimed that neuro-inflammation may contribute to the cause of Parkinson Disease. The risk of Parkinson's Disease in those people taking Ibuprofen was reduced to 62%. There was also a relationship between Parkinson's Disease and the dosage taken per week. However, other drugs of the same type, including aspirin and other NSAIDS, did not lessen the risk of Parkinson's Disease. Other NSAIDS actually increased the risk of Parkinson's Disease. The authors suggest that Ibuprofen should be further investigated for its potential use in Parkinson's Disease.

However, Ibuprofen has never been shown to reduce Parkinson's Disease. Also, it has also not been proven that the claimed relationship between Ibuprofen and Parkinson's Disease is directly due to Ibuprofen.  Long term use of Ibuprofen is also known to be able to cause serious side effects. For more information go to Ibuprofen. In previous studies, the risk of Parkinson's Disease in people taking Ibuprofen was found to be greater than in the present study at 76% complete abstract, and 85% complete abstract. For more current news go to Parkinson's Disease News.

E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News,  please merely e-mail [email protected] with the message "subscribe".  No form of identity is required.  E-mail addresses are not used for any other purpose.

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports